As of 2025-03-21, the Relative Valuation of Solid Biosciences Inc (SLDB) is (12.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.70 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -363.6%.
The range of the Relative Valuation is (6.06) - (18.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 16.4x | 10.6x |
| Forward P/E multiples | 5.1x - 15.3x | 10.2x |
| Fair Price | (6.06) - (18.18) | (12.39) |
| Upside | -228.9% - -486.8% | -363.6% |
| Date | P/E |
| 2025-03-04 | -4.47 |
| 2025-03-03 | -4.31 |
| 2025-02-28 | -4.70 |
| 2025-02-27 | -4.49 |
| 2025-02-26 | -4.45 |
| 2025-02-25 | -4.45 |
| 2025-02-24 | -4.70 |
| 2025-02-21 | -4.86 |
| 2025-02-20 | -5.05 |
| 2025-02-19 | -5.44 |
| 2025-02-18 | -4.46 |
| 2025-02-14 | -3.39 |
| 2025-02-13 | -3.32 |
| 2025-02-12 | -2.97 |
| 2025-02-11 | -2.78 |
| 2025-02-10 | -2.89 |
| 2025-02-07 | -2.42 |
| 2025-02-06 | -2.63 |
| 2025-02-05 | -2.56 |
| 2025-02-04 | -2.56 |
| 2025-02-03 | -2.65 |
| 2025-01-31 | -2.68 |
| 2025-01-30 | -2.79 |
| 2025-01-29 | -2.80 |
| 2025-01-28 | -2.76 |
| 2025-01-27 | -2.64 |
| 2025-01-24 | -2.70 |
| 2025-01-23 | -2.52 |
| 2025-01-22 | -2.63 |
| 2025-01-21 | -2.74 |
| 2025-01-17 | -2.75 |
| 2025-01-16 | -2.74 |
| 2025-01-15 | -2.64 |
| 2025-01-14 | -2.60 |
| 2025-01-13 | -2.79 |
| 2025-01-10 | -3.10 |
| 2025-01-08 | -3.39 |
| 2025-01-07 | -3.30 |
| 2025-01-06 | -3.45 |
| 2025-01-03 | -3.48 |
| 2025-01-02 | -3.28 |
| 2024-12-31 | -3.37 |
| 2024-12-30 | -3.43 |
| 2024-12-27 | -3.57 |
| 2024-12-26 | -3.68 |
| 2024-12-24 | -3.52 |
| 2024-12-23 | -3.45 |
| 2024-12-20 | -3.50 |
| 2024-12-19 | -3.37 |
| 2024-12-18 | -3.39 |